Importation of Prescription Drugs

ICR 202302-0910-012

OMB: 0910-0888

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2023-10-20
IC Document Collections
ICR Details
0910-0888 202302-0910-012
Received in OIRA 202010-0910-005
HHS/FDA CDER
Importation of Prescription Drugs
Extension without change of a currently approved collection   No
Regular 10/20/2023
  Requested Previously Approved
36 Months From Approved 10/31/2023
100 100
6,040 6,040
0 0

This ICR collects information from Section 804 Importation Programs (SIPs), which would be authorized by FDA and overseen by States or certain other governmental entities (SIP Sponsors) that seek to import certain prescription drugs from Canada.

US Code: 21 USC 384 Name of Law: FFDCA; Importation of Prescription Drugs
  
None

Not associated with rulemaking

  88 FR 37549 06/08/2023
88 FR 70995 10/13/2023
Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 100 100 0 0 0 0
Annual Time Burden (Hours) 6,040 6,040 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
We have retained figures from the previous information collection approval. We assume burden pertaining to these information collection activities will be distributed among respondents for an average of 100 responses and 6,040 hours annually.

$163,094
No
    Yes
    No
No
No
No
No
Rachel Showalter 202 693-2146 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/20/2023


© 2024 OMB.report | Privacy Policy